Exact Sciences Gets FDA Nod for Label Expansion of Cologuard

Exact Sciences Corp. EXAS announced that the FDA has approved a label expansion of its noninvasive colorectal cancer screening test, Cologuard.

The test can now be used in eligible average-risk individuals aged 45 years or older, expanding on its previous indication for 50 years or older.